What is the difference between pharmaceutical equivalent and therapeutic equivalence?

What is the difference between pharmaceutical equivalent and therapeutic equivalence? Therapeutic Equivalents: Drug products are considered to be therapeutic equivalents only if they are pharmaceutical equivalents and if they can be expected to have the same clinical effect and safety profile when administered to patients under the conditions specified in the labeling. What is meant […]

What is the Office 2013 Service Pack 1 (sp)?

What is the Office 2013 Service Pack 1 (sp)? Additionally, the SP is a roll-up of all previously released updates. You can get specific information about this update in the Microsoft Knowledge Base article Service Pack 1 for Microsoft Office 2013 (KB2817430) 64-Bit Edition . Is there a 64-bit version of Microsoft Office 2013 language […]

Is Bubble Puppy a boy or girl?

Is Bubble Puppy a boy or girl? Bubble Puppy Age Young Dislikes Rain (formerly), getting sick Species Dog Gender Male What is bubble puppy’s name? In the series, six students—Gil, Molly, Deema, Nonny, Oona, and Goby—learn from their teacher, Mr. Grouper, and play will Gil’s pet, Bubble Puppy. There are also the Little Fish, who […]

Are Hayden and Klitschko still together?

Are Hayden and Klitschko still together? Hayden Panettiere’s Ups and Downs Through the Years Panettiere and Klitschko, who got engaged in 2013, called it quits in 2018. Shortly after ending the engagement, the former child star moved on with Hickerson. What happened to Hayden and Wladimir? Hayden started dating then-world heavyweight boxing champion Wladimir in […]

How many mg of mesalazine are in mezavant XL?

How many mg of mesalazine are in mezavant XL? Mezavant XL 1200 mg, gastro-resistant, prolonged release tablets. 2. Qualitative and quantitative composition Each tablet contains 1200mg mesalazine. What is mezavant used to treat? MEZAVANT contains the active ingredient mesalazine. MEZAVANT is used for the treatment of ulcerative colitis. For more information, see Section 1. Why […]

Back to Top